Effective dose of bevacizumab for the treatment of retinopathy of prematurity

&#350;ahin, Alparslan; Türkcü, Fatih Mehmet; &#350;ahin, Muhammed; Dikci, Seyhan; Ceylan, Osman Melih; Demirel, Soner; Y&#305;lmaz, Turgut

Effective dose of bevacizumab for the treatment of retinopathy of prematurity / A dose eficaz de bevacizumab para o tratamento da retinopatia da prematuridade

Şahin, Alparslan; Türkcü, Fatih Mehmet; Şahin, Muhammed; Dikci, Seyhan; Ceylan, Osman Melih; Demirel, Soner; Yılmaz, Turgut.

Şahin, Alparslan; Batman Private Hospital. Department of Ophthalmology. Batman. TR
Türkcü, Fatih Mehmet; Batman Zilan Hospital. Department of Ophthalmology. Batman. TR
Şahin, Muhammed; Dicle University. School of Medicine. Department of Ophthalmology. Diyarbakır. TR
Dikci, Seyhan; s.af
Ceylan, Osman Melih; s.af
Demirel, Soner; s.af
Yılmaz, Turgut; s.af

Arq. bras. oftalmol ; 81(4): 354-356, July-Aug. 2018.

Article in English | LILACS | ID: biblio-950466

Subject(s)

Humans; Infant, Newborn; Retinopathy of Prematurity; Bevacizumab; Retrospective Studies; Gestational Age; Angiogenesis Inhibitors; Vascular Endothelial Growth Factor A; Intravitreal Injections

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Retinopathy of Prematurity / Bevacizumab Type of study: Observational study Limits: Humans / Infant, Newborn Language: English Journal: Arq. bras. oftalmol Journal subject: Ophthalmology Year: 2018 Type: Article Affiliation country: Turkey Institution/Affiliation country: Batman Private Hospital/TR / Batman Zilan Hospital/TR / Dicle University/TR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google